Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 276-173-3 | CAS number: 71902-23-3
Endpoint summary
Administrative data
Link to relevant study record(s)
Description of key information
No experimental data on toxicokinetics, metabolism and distribution of the submission substance are available. Based on the physicochemical properties of the submission substance it is anticipated that the substance is bioavailable via the oral, dermal or inhalation route. Beta oxidation or direct hydrolysis are thought to be reasonable metabolism pathways leading to systemic exposure to 3,5,5-trimethylhexanoic acid. Given the results from repeated dose experiments no concern for bioaccumulation is raised.
Key value for chemical safety assessment
Additional information
The submission substance is expected to be bioavailable for oral/dermal/inhalation routes based on the given molecular size (MW of 271.4 g/mol) and the octanol water partition coefficient (LogPow 2.47). No metabolism or kinetic study is available on the submission substance. Based on the structural analysis and the indication obtained in the microbial degradation study (metabolite identification in samples of Zahn-Wellens Test), two degradation pathways can be reasonably derived:
- Beta oxidation at the terminal carboxylic acid moiety in combination with hydrolysis at amide bond
- Direct hydrolysis at the amide moiety
Both pathways are leading to systemic exposure to 3,5,5-trimethylhexanoic acid, which serves as surrogates of the proposed read-across approach. The bioaccumulating potential is estimated to be of no concern, because clear recovery effects were observed in the provided 28 -day toxicity studies.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
